|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.080 USD | -8.43% |
|
-6.17% | -9.09% |
| 05-12 | Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-12 | Harvard Bioscience, Inc., Q1 2026 Earnings Call, May 12, 2026 |
| Market Cap | 29.95M 25.87M 23.84M 22.31M 41.81M 2.85B 42.46M 281M 110M 1.39B 112M 110M 4.8B | P/E Ratio 2026 * |
-3.1x | P/E Ratio 2027 * | -13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 29.95M 25.87M 23.84M 22.31M 41.81M 2.85B 42.46M 281M 110M 1.39B 112M 110M 4.8B | EV / Sales 2026 * |
0.34x | EV / Sales 2027 * | 0.32x |
| Free-Float |
92.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Harvard Bioscience, Inc.
| 1 day | -8.43% | ||
| 1 week | -6.17% | ||
| Current month | +3.40% | ||
| 1 month | -11.11% | ||
| 3 months | +19.90% | ||
| 6 months | -18.19% | ||
| Current year | -9.09% |
| 1 week | 5.89 |  | 6.69 |
| 1 month | 4.87 | | 6.69 |
| Current year | 4 | | 7.5 |
| 1 year | 3.76 | | 9.4 |
| 3 years | 2.81 | | 62 |
| 5 years | 2.81 | | 87.5 |
| 10 years | 2.81 | | 87.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Duke
CEO | Chief Executive Officer | 55 | 28/07/2025 |
Mark Frost
DFI | Director of Finance/CFO | 63 | 12/05/2025 |
Diane Houston
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Katherine Eade
BRD | Director/Board Member | 52 | 24/10/2017 |
John Duke
BRD | Director/Board Member | 55 | 02/06/2025 |
Robert Gagnon
BRD | Director/Board Member | 51 | 16/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-09 | Free | Director | 16,556 | 0.3671% | ||
| 06-09 | Free | Director | 16,556 | 0.3671% | ||
| 06-09 | Free | Director | 16,556 | 0.3671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.43% | -6.17% | +5.12% | -88.86% | 29.95M | |
| -1.33% | -2.63% | +13.05% | -9.43% | 177B | |
| -0.45% | -1.85% | -21.31% | +31.43% | 146B | |
| -0.38% | -3.50% | -12.03% | -23.48% | 128B | |
| -0.55% | -3.97% | -52.81% | -8.52% | 70.11B | |
| -0.76% | -2.68% | +12.77% | +1.20% | 49.38B | |
| +0.67% | -0.06% | -25.59% | -33.84% | 44.23B | |
| +0.22% | -6.16% | +8.45% | +12.13% | 36.59B | |
| -1.17% | -5.56% | +2.74% | +42.62% | 35.32B | |
| +1.04% | +2.15% | -11.20% | -15.46% | 29.35B | |
| Average | -1.11% | -1.64% | -8.08% | -9.22% | 71.6B | |
| Weighted average by Cap. | -0.56% | -1.98% | -9.04% | -0.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 88.6M 76.52M 70.52M 66.01M 124M 8.42B 126M 833M 325M 4.1B 333M 325M 14.19B | 94.2M 81.36M 74.97M 70.18M 132M 8.95B 134M 885M 345M 4.36B 354M 346M 15.09B |
| Net income | -9.05M -7.82M -7.2M -6.74M -12.64M -860M -12.83M -85.05M -33.16M -419M -33.96M -33.24M -1.45B | -2.05M -1.77M -1.63M -1.53M -2.86M -195M -2.91M -19.27M -7.51M -94.84M -7.69M -7.53M -328M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 6.080 $ | -8.43% | 30,437 |
| 11/06/26 | 6.640 $ | +7.10% | 35,418 |
| 10/06/26 | 6.200 $ | +2.65% | 11,689 |
| 09/06/26 | 6.040 $ | +0.50% | 16,552 |
| 08/06/26 | 6.010 $ | -2.99% | 10,604 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HBIO Stock
Select your edition
All financial news and data tailored to specific country editions
